Back
Unity Software Vs. Keros Therapeutics Industry Stock Comparison
Buy
55
U
Unity Software
Last Price:
$22.82
Seasonality Move:
21.86%
Sell
29
KROS
Keros Therapeutics
Last Price:
$14.10
Seasonality Move:
-10.32%
Buy
55
Unity Software (U)
is a Buy
Is Unity Software a Buy, Sell or Hold?
-
The current Unity Software [U] share price is $22.81. The Score for U is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
U is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
29
Keros Therapeutics (KROS)
is a Sell
Is Keros Therapeutics a Buy, Sell or Hold?
-
The current Keros Therapeutics [KROS] share price is $14.07. The Score for KROS is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
-
KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
U Stock Price Chart
What is Unity Software's stock price today?
-
The Unity Software share price today is $22.81Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and U is experiencing buying pressure, which is a positive indicator for future bullish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $14.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.
U Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.35 | Buy |
Relative Strength Index (14 RSI): | 60.76 | Buy |
Chaikin Money Flow: | 9672758 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.6 - 22.12) | Buy |
Bollinger Bands (100): | (19.74 - 23.96) | Buy |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.36 | Buy |
Relative Strength Index (14 RSI): | 58.61 | Buy |
Chaikin Money Flow: | 220521 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.33 - 14.49) | Buy |
Bollinger Bands (100): | (10.46 - 14.38) | Buy |
U Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 21.4 | Buy |
20-day SMA: | 21.36 | Buy |
50-day SMA: | 20.73 | Buy |
200-day SMA: | 21.05 | Buy |
8-day EMA: | 21.67 | Buy |
20-day EMA: | 21.24 | Buy |
50-day EMA: | 21.19 | Buy |
200-day EMA: | 21.97 | Buy |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.79 | Buy |
20-day SMA: | 14.1 | Sell |
50-day SMA: | 12.42 | Buy |
200-day SMA: | 33.08 | Sell |
8-day EMA: | 13.89 | Buy |
20-day EMA: | 13.68 | Buy |
50-day EMA: | 13.63 | Buy |
200-day EMA: | 27.09 | Sell |
Unity Software Earnings Growth & U Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.12 per share, and an increase next year of $0.05 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.02 per share, an increase this year of $4.38 per share, and a decrease next year of $4.60 per share.
Unity Software Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |